Palliative Surgery for Head and Neck Cancer with Extensive Skin Involvement

被引:14
|
作者
Jang, David W. [1 ]
Teng, Marita S. [1 ]
Ojo, Bukola [1 ]
Genden, Eric M. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Otolaryngol Head & Neck Surg, New York, NY USA
来源
LARYNGOSCOPE | 2013年 / 123卷 / 05期
关键词
Palliative surgery; advanced head and neck cancer; skin involvement; free flap; MICROSURGERY; RESECTION; PATIENT;
D O I
10.1002/lary.23657
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: To evaluate the role of regional and free tissue transfer for the palliative management of head and neck cancer with extensive skin involvement. Study Design: Case Series. Methods: A retrospective review was performed of patients treated for head and neck cancer with involvement of the skin at the Mount Sinai Medical Center over a 5-year period (2006-2010). Only patients with extensive skin involvement and unresectable tumors who underwent palliative resection and reconstruction were included in the review. Subjects were analyzed for age, gender, performance status, primary site, tumor histology, extent of invasion, type of reconstruction, hospital course, wound complications, adjuvant therapy, survival, and cause of death. Results: Twenty-five patients met the inclusion criteria for the review. Fourteen patients (56%) underwent regional flap reconstruction, and 11 patients (44%) underwent free flap reconstruction. The average length of stay was 7 days. Twenty-four patients (96%) had a medically uncomplicated postoperative hospital course. Nineteen patients (76%) were treated with adjuvant palliative radiotherapy and/or chemotherapy. Long-term follow-up was achieved for 19 patients. The median follow up in this group was 9.5 months. Eleven of the 21 patients (52%) developed wound complications postoperatively. Eight of these were minor wound dehiscences, while three developed major wound complications. Four patients (16%) had distant metastasis at the time of surgery, and the median time to develop distant metastases after surgery was 6 months. Median survival time was 9.5 months. Twenty-two patients (88%) were discharged in the care of their families with appropriate pain management and without the need for extensive wound care. Conclusions: For unresectable tumors with extensive skin involvement, palliative resection and reconstruction is a reasonable treatment option. Although survival may not be affected, addressing the odor, bleeding, pain, and infection associated with skin involvement has the potential to improve a patient's quality of life.
引用
收藏
页码:1173 / 1177
页数:5
相关论文
共 50 条
  • [21] Surgery for head and neck skin tumors in the elderly
    Dhiwakar, Muthuswamy
    Khan, Najib A.
    McClymont, Leo G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (09): : 851 - 856
  • [22] COMPLICATIONS OF SKIN GRAFTING IN HEAD AND NECK SURGERY
    KING, GD
    SURGICAL CLINICS OF NORTH AMERICA, 1957, 37 (03) : 587 - 592
  • [23] Palliative Radiotherapy in Breast Cancer with Skin Involvement
    Min, S.
    Byun, H. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E324 - E324
  • [24] The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK
    Hopper, C
    Niziol, C
    Sidhu, M
    ORAL ONCOLOGY, 2004, 40 (04) : 372 - 382
  • [26] EXPERIENCE WITH ISOVOLEMIC HEMODILUTION IN EXTENSIVE HEAD AND NECK-SURGERY
    MACKAY, ZUH
    DIN, MU
    DARZI, MA
    CHOWDRI, NA
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1995, 95 (03) : 479 - 485
  • [27] Facial node involvement in head and neck cancer
    Sheahan, P
    Colreavy, M
    Toner, M
    Timon, CVI
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (06): : 531 - 536
  • [28] MicroRNAs Involvement in Radioresistance of Head and Neck Cancer
    Ahmad, Parwez
    Sana, Jiri
    Slavik, Marek
    Slampa, Pavel
    Smilek, Pavel
    Slaby, Ondrej
    DISEASE MARKERS, 2017, 2017
  • [29] PALLIATIVE CISPLATIN AND CAPECITABINE CHEMOTHERAPY IN HEAD AND NECK CANCER
    Califano, R.
    Jyoti, B.
    Hodgson, C.
    Mais, K.
    Lee, L. W.
    ANNALS OF ONCOLOGY, 2010, 21 : 327 - 327
  • [30] Palliative Reconstruction for the Management of Incurable Head and Neck Cancer
    Miglani, Amar
    Patel, Viraj M.
    Stern, Carrie S.
    Weichman, Katie E.
    Haigentz, Missal, Jr.
    Ow, Thomas J.
    Garfein, Evan S.
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2016, 32 (03) : 226 - 232